MilliporeSigma
  • Home
  • Search Results
  • Excreted/secreted Trichuris suis products reduce barrier function and suppress inflammatory cytokine production of intestinal epithelial cells.

Excreted/secreted Trichuris suis products reduce barrier function and suppress inflammatory cytokine production of intestinal epithelial cells.

Molecular immunology (2014-04-08)
I H Hiemstra, E J Klaver, K Vrijland, H Kringel, A Andreasen, G Bouma, G Kraal, I van Die, J M M den Haan
ABSTRACT

The administration of helminths is considered a promising strategy for the treatment of autoimmune diseases due to their immunomodulatory properties. Currently, the application of the helminth Trichuris suis as a treatment for Crohn's disease is being studied in large multi-center clinical trials. The intestinal epithelium forms an efficient barrier between the intestinal lumen containing the microbial flora and helminths, and dendritic cells (DCs) present in the lamina propria that determine the TH response. Here, we investigated how excreted/secreted (E/S) products of T. suis affect the barrier function of intestinal epithelial cells (IECs) in order to reach the DCs and modulate the immune response. We show that T. suis E/S products reduce the barrier function and the expression of the tight junction proteins EMP-1 and claudin-4 in IEC CMT93/69 monolayers in a glycan-dependent manner. This resulted in an increased passage of soluble compounds to the basolateral side that affected DC function. In addition, T. suis E/S suppressed LPS-induced pro-inflammatory cytokine production by CMT93/69 cells, whereas the production of the TH2 response-inducing cytokine thymic stromal lymphopoietin (TSLP) was induced. Our studies indicate that T. suis E/S glycans affect the function of the intestinal epithelium in order to modulate DC function. Identification of the T. suis E/S glycans that modulate IEC and DC function may lead to a strategy to reduce symptoms of autoimmune and allergic immune diseases by orally administrated helminth-derived factors without the need of infection with live helminths.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Sodium periodate, 10 wt. %, matrix silica gel support
Sigma-Aldrich
Sodium periodate, ACS reagent, ≥99.8%
Sigma-Aldrich
Sodium borohydride, ReagentPlus®, 99%
Sigma-Aldrich
Sodium borohydride, purum p.a., ≥96% (gas-volumetric)
Sigma-Aldrich
Sodium borohydride, granular, 99.99% trace metals basis
Sigma-Aldrich
Sodium borohydride, caplets (18 × 10 × 8 mm), 98%
Sigma-Aldrich
Sodium borohydride, 90% NaBH4 basis, pellets, diam. 8 mm, Cobalt (Doped)
Sigma-Aldrich
Sodium borohydride, hydrogen-storage grade, 98%
Sigma-Aldrich
Sodium borohydride, powder, ≥98.0%
Sigma-Aldrich
Mouse KC / CXCL1 ELISA Kit, for serum, plasma and cell culture supernatant
Sigma-Aldrich
Sodium borohydride, granular, 10-40 mesh, 98%
Sigma-Aldrich
Human GRO-α / CXCL1 ELISA Kit, for serum, plasma, cell culture supernatant and urine
Sigma-Aldrich
Sodium (meta)periodate, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99.8%
Sigma-Aldrich
Sodium (meta)periodate, ≥99.0%
Sigma-Aldrich
Sodium borohydride solution, 2.0 M in triethylene glycol dimethyl ether
Sigma-Aldrich
Sodium borohydride solution, ~12 wt. % in 14 M NaOH
Sigma-Aldrich
Sodium borohydride solution, 0.5 M in 2-methoxyethyl ether
Sigma-Aldrich
Sodium (meta)periodate, BioUltra, ≥99.5% (RT)
Sigma-Aldrich
Rat CINC-1 ELISA Kit, for serum, plasma and cell culture supernatant
Sigma-Aldrich
VenPure® SF, powder